No, of course not. It’s a disingenuous rationale to lower the modeled market-share target for Daxxify.
It is also disingenuous to provide precise low number Daxxify sales in aesthetics by 2030 but not do the same for CD by 2030. Well, unless the analyst assume there won't be any Daxxify sales in CD worth mentioning.
Market Data 
Markets 
AI
